健康与医疗系统
5 key trends for the future of healthcare
A human embryo’s DNA is “edited” to take out a disease. Surgeons practice complicated procedures on models created by 3-D printers. A pre-programmed drone collects blood samples from resi...
Albert Bourla
Doctor of Veterinary Medicine; PhD in the Biotechnology of Reproduction, Veterinary School of Aristotle University. Almost 25 years of experience with Pfizer and has held a number of senior global positions across a range of markets and disciplines. 1993, joined Pfizer's Animal Health Division as Technical Director, Greece. Held positions of increasing responsibility across Europe. 2001, moved to Pfizer Global Headquarters in New York to assume the role of US Group Marketing Director for Animal Health. 2004, became Vice-President, Business Development and New Products Marketing. 2006, appointed Area President, Europe, Africa and Middle East. 2009, assumed additional responsibilities for Asia and Pacific. Former President and General Manager, Pfizer's Established Products Business; led the development and implementation of strategies and tactics related to Pfizer's off-patent portfolio. Former Group President, Pfizer's Global Vaccines, Oncology and Consumer Healthcare Business. Currently, Group President, Pfizer Innovative Health. Member, Executive Leadership Team, Pfizer. Member of the Board: Pfizer Foundation, which promotes access to quality healthcare; Biotechnology Innovation Organization (Bio), the world's largest biotechnology trade association, serving on the Executive Committee.
最热内容